Resource Summary Report  New Search

URL: http://www.predect.eu/

Proper Citation: PREDECT (RRID:SCR_003883)

Description: Project that aims to create more appropriate in vitro platforms for target validation and drug discovery for breast, prostate and lung cancers. Laboratory platforms to validate whether target modulation would provide a clinical benefit are usually highly reductionist, often using long-established cell lines growing in 2 dimensions in vitro. These models do not reflect the complexity and heterogeneity of a tumor in situ, where biochemical pathways are wired with connections to the complex tumor environment provided by the stroma. PREDECT has the goal of comparing the pathological and molecular profiles of novel in vitro platforms with those of human tumors. Because obtention of clinical material presents both logistics and quality problems for ongoing and intense studies of target validation, PREDECT aims to use material from genetically engineered mouse models, and some advanced xenografts, whose pathology and molecular profiles closely match cohorts of human tumors. PREDECT hopes to provide more appropriate in vitro platforms both for target validation and subsequent preclinical studies which will replace a current cascade of tests which are poorly predictive of clinical activity. The project is expected to shift paradigms in cell biology as well as in preclinical target validation where it should permit greater predictivity of drug efficacy in patient cohorts.

Abbreviations: PREDECT

Synonyms: Preclinical evaluation of drug efficacy in common solid tumours, Predect New models for preclinical evaluation of drug efficacy in common solid tumours

Resource Type: portal, consortium, organization portal, data or information resource

Keywords: drug, oncology, drug development, basic research, in vitro, xenograft, breast, prostate, lung, pre-clinical, target validation, drug discovery